RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Catalyst Biosciences Stock

Catalyst Biosciences ROCE 2024

Catalyst Biosciences ROCE

-2.53

Ticker

CBIO

ISIN

US14888D2080

WKN

A2DLUK

In 2024, Catalyst Biosciences's return on capital employed (ROCE) was -2.53, a 18.31% increase from the -2.14 ROCE in the previous year.

Catalyst Biosciences Aktienanalyse

What does Catalyst Biosciences do?

Catalyst Biosciences Inc. is a biotechnology company specializing in the development of innovative therapies for rare diseases and severe bleeding disorders. They collaborate with doctors, academics, and patient organizations to bring new treatment options to the market. Their business model is based on the development of proteins that influence the blood clotting process to prevent or reduce bleeding. They use a proprietary technology called Protease Engineering Platform (PEP) to make customized proteins. Catalyst Biosciences Inc. focuses on therapies for rare diseases such as hemophilia A and B, hemorrhagic diathesis, and other rare diseases like factor XIII deficiency or thrombasthenia. They offer a range of products, including CB 2679d, CB 813d, and CB 2679f for the treatment of hemophilia B. Catalyst Biosciences Inc. has achieved milestones and is considered one of the most promising companies in the industry. With its innovative technology and comprehensive portfolio, it has the potential for further success. Catalyst Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Catalyst Biosciences's Return on Capital Employed (ROCE)

Catalyst Biosciences's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Catalyst Biosciences's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Catalyst Biosciences's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Catalyst Biosciences’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Catalyst Biosciences stock

What is the ROCE (Return on Capital Employed) of Catalyst Biosciences this year?

The ROCE of Catalyst Biosciences is -2.53 undefined this year.

How has the ROCE (Return on Capital Employed) of Catalyst Biosciences developed compared to the previous year?

The ROCE of Catalyst Biosciences has increased by 18.31% increased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Catalyst Biosciences?

A high Return on Capital Employed (ROCE) indicates that Catalyst Biosciences has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Catalyst Biosciences?

A low ROCE (Return on Capital Employed) can indicate that Catalyst Biosciences has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Catalyst Biosciences impact the company?

An increase in the ROCE of Catalyst Biosciences can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Catalyst Biosciences affect the company?

A decrease in ROCE of Catalyst Biosciences can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Catalyst Biosciences?

Some factors that can affect Catalyst Biosciences's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Catalyst Biosciences so important for investors?

The ROCE of Catalyst Biosciences is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Catalyst Biosciences take to improve the ROCE?

To improve the ROCE, Catalyst Biosciences can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Catalyst Biosciences pay?

Over the past 12 months, Catalyst Biosciences paid a dividend of 1.43 USD . This corresponds to a dividend yield of about 8.01 %. For the coming 12 months, Catalyst Biosciences is expected to pay a dividend of 0.24 USD.

What is the dividend yield of Catalyst Biosciences?

The current dividend yield of Catalyst Biosciences is 8.01 %.

When does Catalyst Biosciences pay dividends?

Catalyst Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Catalyst Biosciences?

Catalyst Biosciences paid dividends every year for the past 0 years.

What is the dividend of Catalyst Biosciences?

For the upcoming 12 months, dividends amounting to 0.24 USD are expected. This corresponds to a dividend yield of 1.34 %.

In which sector is Catalyst Biosciences located?

Catalyst Biosciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Catalyst Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Catalyst Biosciences from 1/12/2023 amounting to 0.24 USD, you needed to have the stock in your portfolio before the ex-date on 1/13/2023.

When did Catalyst Biosciences pay the last dividend?

The last dividend was paid out on 1/12/2023.

What was the dividend of Catalyst Biosciences in the year 2023?

In the year 2023, Catalyst Biosciences distributed 1.43 USD as dividends.

In which currency does Catalyst Biosciences pay out the dividend?

The dividends of Catalyst Biosciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Catalyst Biosciences

Our stock analysis for Catalyst Biosciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Catalyst Biosciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.